Age and Sex Differences in the Treatment of Patients with Initial Acute Myocardial Infarction: A Community-Wide PerspectiveHarrold L.R. · Lessard D. · Yarzebski J. · Gurwitz J.H. · Gore J.M. · Goldberg R.J.
Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Mass., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Purpose: The goal of this observational study was to examine overall and age-specific differences between women and men in the use of five beneficial cardiac medications in patients hospitalized with acute myocardial infarction (AMI) from a community-wide perspective. The objectives of our study were to determine whether women are treated differently than men and whether age acts as a potential effect modifier of any observed associations. Subjects: A total of 2,461 women and 3,454 men with validated AMI comprised the study sample. Methods: Our study was an observational investigation of metropolitan Worcester (Mass., USA) residents who were hospitalized with initial AMI in all area hospitals during 12 1-year periods between 1975 and 1999. Four age-specific subgroups (<55, 55–64, 65–74 and ≧75 years) were studied. Results: Differences in the use of angiotensin-converting enzyme (ACE) inhibitors, aspirin, β-blockers, lipid-lowering medications and thrombolytic agents during hospitalization for AMI were examined. The results of a multivariable regression analysis indicated that women were significantly less likely to receive aspirin and ACE inhibitors as compared to men. There were no significant gender differences in the prescribing of the other cardiac medications. Increasing age in both women and men was associated with a reduced likelihood of receiving effective cardiac therapies including aspirin, β-blockers, lipid-lowering therapy and thrombolytic agents. Conclusions: These data suggest that the reasons for the marked age-related differences, in men and women, in the use of cardiac medications be more systematically explored. Previously observed gender differences in the management of patients with AMI essentially no longer exist.
© 2003 S. Karger AG, Basel
American Heart Association: 2000 Heart Stroke Statistical Update. Dallas, American Heart Association, 1999.
- Wenger NK, Speroff L, Packard B: Cardiovascular health and disease in women. N Engl J Med 1993;329:247–256.
- Maynard C, Litwin PE, Martin JS, Weaver WD: Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. Arch Intern Med 1992;152:972–976.
- Nohria A, Vaccarino V, Krumholz HM: Gender differences in mortality after myocardial infarction. Why women fare worse than men. Cardiol Clin 1998;16:45–57.
- Vaccarino V, Krumholz HM, Yarzebski J, Gore JM, Goldberg RJ: Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med 2001;134:173–181.
- McLaughlin TJ, Soumerai SB, Willison DJ, Gurwitz JH, Borbas C, Guadagnoli E, et al: Adherence to national guidelines for drug treatment of suspected acute myocardial infarction. Evidence for undertreatment in women and the elderly. Arch Intern Med 1996;156:799–805.
- Pashos CL, Normand SL, Garfinkle JB, Newhouse JP, Epstein AM, McNeil BJ: Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol 1994;23:1023–1030.
- Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, McNeil BJ: Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA 1992;268:2530–2536.
- Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, et al: Sex, clinical presentation and outcome in patients with acute coronary syndromes. N Engl J Med 1999;341:226–232.
Goldberg RJ, Gore JM, Alpert JS, Dalen JE: Recent changes in the attack rates and survival rates of acute myocardial infarction (1975–1984): The Worcester Heart Attack Study. JAMA 1986;255:2774–2779.
- Goldberg RJ, Gorak EJ, Yarzebski J, Hosmer DW Jr, Dalen P, Gore JM, et al: A community-wide perspective of sex-differences and temporal trends in the incidence and survival rates following acute myocardial infarction and out-of-hospital deaths due to coronary heart disease. Circulation 1993;87:1947–1953.
- Goldberg RJ, Yarzebski J, Lessard D, Gore JM: A two-decade (1975–1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: A community-wide perspective. J Am Coll Cardiol 1999;33:1533–1539.
- Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM: Temporal trends (1975–1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction (Worcester Heart Attack Study). N Engl J Med 1999;340:1162–1168.
- Spencer FA, Meyer TE, Goldberg RJ, Yarzebski J, Hatton M, Lessard D, et al: Twenty year trends (1975–1995) in the incidence, in-hospital, and long-term death rates associated with heart failure complicating acute myocardial infarction: A community-wide perspective. J Am Coll Cardiol 1999;34:1378–1387.
- Spencer F, Scleparis G, Goldberg RJ, Yarzebski J, Lessard D, Gore JM: Decade long trends (1986–1997) in the medical management of patients with acute myocardial infarction: A community-wide perspective. Am Heart J 2001;142:594–603.
- Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM: Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999;341:217–225.
- Gan SC, Beaver SK, Houck PM, MacLehose RF, Lawson HW, Chan L: Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med 2000;343:8–15.
- Chandra NC, Ziegelstein RC, Rogers WJ, Tiefenbrunn AJ, Gore JM, French WJ, Rubison M for the National Registry of Myocardial Infarction-I: Observations of the treatment of women in the United States with myocardial infarction: A report from the National Registry of Myocardial Infarction-I. Arch Intern Med 1998;158:981–988.
Rathore SS, Berger AK, Weinfurt KP, Feinleib M, Oetgen WJ, Gersh BJ, Schulman KA: Race, sex, poverty, and the medical treatment of acute myocardial infarction in the elderly. Circulation 2000;102:642–648.
- Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ: Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. Ann Intern Med 1996;124:283–291.
- Chandra H, Yarzebski J, Goldberg RJ, Savageau J, Singleton C, Gurwitz JH, et al: Age-related trends (1986–1993) in the use of thrombolytic agents in patients with acute myocardial infarction: The Worcester Heart Attack Study. Arch Intern Med 1997;157:741–746.
- Krumholz HM, Radford MJ, Wang U, Chen J, Heiat A, Marciniak TA: National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 1998;280:623–629.
- Krumholz HM, Radford MJ, Ellerbeck EF, Hennen J, Meehan TP, Petrillo M, et al: Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes. Ann Intern Med 1996;124:292–298.
- Heidenreich PA, McClellan M: Trends in treatment and outcomes for acute myocardial infarction: 1975–1995. Am J Med 2001;110:165–174.
- Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, et al: Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation 1994;90:2103–2114.
- Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, and the GUSTO-1 investigators: Regional variation across the United States in the management of acute myocardial infarction. N Engl J Med 1995;333:565–572.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.